Yamada rejoins Frazier Healthcare

Frazier Healthcare said Monday that Tadataka Yamada, Ph.D., has rejoined the firm as a Venture Partner on the Life Sciences team. He will also serve as a Senior Advisor to the Growth Buyout team. Before rejoining Frazier, Dr. Yamada was Chief Medical and Scientific Officer at Takeda Pharmaceuticals in Tokyo, as well as a member of the Board of Directors.

PeopleNorth AmericaUSBriefs